willow semaglutide reviews GLP-1 Review: Flat-Rate Pricing, Mixed Joi Wellness vs. Willow for
Description
Prescriptions made for GLP-1 agonists under various brand names (e.g., Ozempic, Wegovy) have more than tripled since 2020
Better weight control often means better insulin sensitivity, improved blood sugar management, and potentially slower progression of Type 2 diabetes
Novo Nordisk's semaglutide patents expire between 2026-2033 depending on formulation and jurisdiction
Clinical insight: Reduces impulsive eating by 23% when paired with structured meal timing
Semaglutide exerts its effects through several interconnected mechanisms
Only 40% of 2023 initiators remained on therapy after a year compared to 34% of 2022 initiators and 33% of 2021 initiators
